UK SABR Consortium 2025 - Annual Conference
We were delighted to have both oral and poster presentations accepted at the 2025 SABR Consortium - the UK's largest specialist meeting for Stereotactic Ablative Radiotherapy.
The conference highlighted new trials, advancements in SABR for conditions like oligometastatic prostate cancer and renal cancer, and innovative technology in radiotherapy treatment.
This event was a valuable platform enabling us to share our collaboration with university of Oxford, Oxford University Hospitals NHS Trust to deliver a British Heart Foundation funded phase I clinical trial of MRI-guided ultra-hypofractionated radiotherapy for ventricular arrhythmia. Download our posters below:
- Stellate ganglia for ventricular arrhythmia (RADIO-STAR trial) – poster Download PDF
- Stellate ganglia radiotherapy-commissioning Download presentation
